![](/img/cover-not-exists.png)
Omalizumab, an Anti-IgE mAb, Receives Approval for the Treatment of Chronic Idiopathic/Spontaneous Urticaria
Wu, Keith C P, Jabbar-Lopez, Zarif KVolume:
135
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1038/jid.2014.362
Date:
January, 2015
File:
PDF, 111 KB
english, 2015